FDA To Issue Remarketer Labeling Regs, Monitor Registration System
This article was originally published in The Gray Sheet
Executive Summary
Device remarketers that label serviced devices as "ready for clinical use" under a recently proposed voluntary registration system will be subject to FDA enforcement action if the devices do not meet performance specifications, according to FDA staffers.
You may also be interested in...
FDA Reuse Policy Demands Data From Both OEMs And Reprocessors
FDA's revised policy on reprocessing of disposable medical devices would require manufacturers seeking to label a product as single-use only to submit data demonstrating that it cannot adequately be reprocessed, FDA staffers report.
Extensive Labeling Required Under Device Remarketers' Voluntary System
Device remarketers and servicers should indicate whether reserviced devices are "ready for clinical use" or "must be checked for proper performance and safety" under a proposed voluntary registration system issued Sept. 9 by an industry task force coordinated by the Association for the Advancement of Medical Instrumentation.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.